|Day Low/High||100.78 / 102.48|
|52 Wk Low/High||72.67 / 125.52|
Contributor Ken Shreve takes a look at economic data and earnings reports scheduled for this week.
Mark Sperling of T3Live review the day's market action and sets up your trading plan for the next session.
Alexion Pharmaceuticals and Intuitive Surgical are leaders in a top-performing sector.
The light volume keeps me hesitant, though here are a few recent standout names.
The biotechnology sector has weathered the correction and looks ready to push higher.
Contributor Ken Shreve takes a look at economic data and earnings reports scheduled for the coming week.
The high-fliers I have been showing can reap huge returns, but make sure you can handle the volatility.
The shares are highly likely to test $100. Just keep a trailing stop on any existing positions.
With only one drug on the market, the pharmaceutical company is expanding its pipeline.
News that Greece will need further austerity measures dragged down world markets and U.S. futures.
Stocks were poised for a moderately higher ahead of this highly anticipated monthly event.
Despite the massive upsurge, there are still a few interesting setups to consider here.
It's not that the market action is bad, it just isn't lively enough to support aggressive action.
Some breakouts, like that of Apple lately, cannot be taken at face value -- especially if they lack volume.
EBIX broke out on Tuesday in heavy volume, which hints at institutional buying in this stock.